Amongthe invasive carcinomas, the most common molecular subtype was luminal B, which wasseen in 28 (45.9%) of the patients, followed by luminal A in 12 (19.7%),triple-negative in 10 (16.4%), and HER-2 in 7 (11.5%). Here, ERBB2 is linked to invasive carcinoma.